FindTrial
Sign In

To compare the results of radiofrequency based session versus combined 20-35 percent Glycolic acid peel and Subcutaneous incision of acne scars and radiofrequency for treatment of atrophic acne scars.

Comparing the efficacy of Microneedling fractional radiofrequency versus combined 20-35 percent Glycolic acid peel and Subscision and Microneedling fractional radiofrequency for the treatment of atrophic acne scars. - Nil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103353
Enrollment
60
Registered
2026-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Combined 20-35 percent Glycolic acid peel and Subscision and Microneedling fractional radiofrequency versus: Combined 20-35percent glycolic acid peel and Subscision and Microneedling fr

Sponsors

Madras medical college and hospital, RGGGH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients of age more than 18 years of both the genders who are diagnosed and classified as atrophic Acne scar clinically. 2. Patients who have given consent for the study. 3. Patients who are willing to come for regular

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women. 2.Patients taking oral contraceptive pills or hormonal replacement therapy at the time of study or during the past 12 months. 3.Concomitant use of anticoagulants or Patients with history of bleeding diathesis. 4.Patients with history of hypertrophic scar & keloids. 5.Active skin infection in the area of acne scar. 6.History of photosensitivity.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of monotherapy versus combination therapy in the treatment of atrophic acne scar.Outcome will be assessed at baseline(0),4,8 and12 weeks and at the end of 3rd month after last sitting using Goodman and Baron qualitative acne scar score. Timepoint: To compare the efficacy of monotherapy versus combination therapy in the treatment of atrophic acne scar.Outcome will be assessed at baseline(0),4,8 and12 weeks and at the end of 3rd month after last sitting using Goodman and Baron qualitative acne scar score.—

Secondary

MeasureTime frame
To analyse the number of sessions needed for the visual improvement, sustainability of results & safety outcomes in a patient with atrophic acne scar.Outcome will be assessed at baseline(0week),4,8,12th week & at the end of 3rd month after last sittingTimepoint: Physician will be Scored as Bad,Good And Excellent using visual improvementscale.Outcome will be assessed at baseline(0week),4,8,12th week & at the end of 3rd month after last sitting—

Countries

India

Contacts

Public ContactDrVithiyasri S

Madras medical college and hospital,RGGGH

rajderm0002@gmail.com9677206655

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026